Clinical Trials Directory

Trials / Completed

CompletedNCT03046576

Prognostic Value of Plasma DPP4 Activity in ST-elevation Myocardial Infarction Patients

The Association Between Plasma DPP4 Activity And Prognosis of Patients With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Status
Completed
Phase
Study type
Observational
Enrollment
625 (actual)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Increased plasma DPP4 activity (DPP4a) could predict both subclinical and new-onset atherosclerosis, and our previous study has found that the DPP4a was significantly lower in MI patients compared with patients having chest pain or unstable angina alone, and DPP4a is associated with no-reflow and major bleeding events in STEMI patients during hospital stay. As no-reflow phenomenon and major bleeding events independently associates with a worse in-hospital and long-term prognosis. One may speculate that the DPP4a is associated with long-term follow-up adverse cardiovascular events in these patients.The hypothesis was tested in this study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTplasma DPP4 activityDPP4a was determined by enzymatic assays.

Timeline

Start date
2013-01-01
Primary completion
2015-09-30
Completion
2015-09-30
First posted
2017-02-08
Last updated
2017-07-21

Source: ClinicalTrials.gov record NCT03046576. Inclusion in this directory is not an endorsement.